Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. May 28, 2005; 11(20): 3105-3111
Published online May 28, 2005. doi: 10.3748/wjg.v11.i20.3105
Published online May 28, 2005. doi: 10.3748/wjg.v11.i20.3105
Figure 2 Effect of the study drug on IBDQ scores.
A: Mean IBDQ scores (±SE) at baseline (wk 0, open bars) as compared to end of treatment (wk 16, black bars); B: IBDQ score of individual patients at baseline as compared to wk 16.
- Citation: Israeli E, Goldin E, Shibolet O, Klein A, Hemed N, Engelhardt D, Rabbani E, Ilan Y. Oral immune regulation using colitis extracted proteins for treatment of Crohn’s disease: Results of a phase I clinical trial. World J Gastroenterol 2005; 11(20): 3105-3111
- URL: https://www.wjgnet.com/1007-9327/full/v11/i20/3105.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i20.3105